‘Much-needed hope’ as CRISPR gene editing therapy recommended for sickle cell disease
Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to new health guidelines which were hailed as marking a “significant shift” in treatment for the blood disorder.


